本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artiva Biotherapeutics, Inc.

6.34
-0.4300-6.35%
成交量:35.31万
成交额:225.32万
市值:3.10亿
市盈率:-1.98
高:6.74
开:6.74
低:6.24
收:6.77
52周最高:14.53
52周最低:2.71
股本:4,888.58万
流通股本:1,908.94万
量比:1.08
换手率:1.85%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
净资产收益率:-36.58%
总资产收益率:-22.34%
市净率:0.89
市盈率(LYR):-1.85

数据加载中...

2026/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses